Sussman Norman 4
4 · DURECT CORP · Filed Sep 11, 2024
Insider Transaction Report
Form 4
DURECT CORPDRRX
Sussman Norman
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-12-10$1.05/sh−9,000$9,495→ 0 total
Footnotes (2)
- [F1]This Form 4 is being filed late due to an inadvertent administrative error. The sale reported herein was executed by the account manager for the benefit of the Reporting Person's managed account, without any instruction from or knowledge of the Reporting Person.
- [F2]The number of shares and price are pre-the company's 10:1 reverse stock split and the numbers do not reflect the stock split.